Cardiac Output Measurement Clinical Trial
In high-risk patients, it is now recommended to guide the intraoperative volume replacement
via the stroke volume.
Today, the most commonly used technique for estimating the stroke volume is the
transpulmonary thermodilution and the arterial waveform analysis in the radial artery by
PICCO®.
This technique has the disadvantage of being invasive and increasing the time dedicated to
anesthesia during the surgery.
The future is the non-invasive monitoring of stroke volume. Thus, Edwards Life Science has
developed a continuous monitoring technology and non-invasive arterial pressure, cardiac
output and stroke volume using a digital sensor (ClearSight®). This continuous monitoring of
blood pressure was validated in cardiothoracic surgery but studies about monitoring cardiac
output or stroke volume are inconclusive and contradictory.
The objective of this study is to compare the use of non-invasive monitoring of stroke volume
by ClearSight® with the transpulmonary thermodilution and the arterial waveform analysis in
radial artery by PICCO® in abdominal major surgery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01678950 -
MostCare Versus Echo-Doppler for Cardiac Output Measurement
|
N/A | |
| Completed |
NCT02717468 -
Comparative Noninvasive Continuous Cardiac Output by the Clearsight With Invasive Monitoring by Pulsioflex in Abdominal Surgery
|
N/A | |
| Recruiting |
NCT05754489 -
Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy
|